Nilsson J - Search Results

1

Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.

Gonçalves I, Nitulescu M, Ares MP, Fredrikson GN, Jansson B, Li ZC, Nilsson J. Gonçalves I, et al. Among authors: nilsson j. Atherosclerosis. 2009 Jul;205(1):96-100. doi: 10.1016/j.atherosclerosis.2008.11.020. Epub 2008 Nov 30. Atherosclerosis. 2009. PMID: 19150065

2

Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation.

Dichtl W, Ares MP, Jönson AN, Jovinge S, Pachinger O, Giachelli CM, Hamsten A, Eriksson P, Nilsson J. Dichtl W, et al. Among authors: nilsson j. Metabolism. 2002 Mar;51(3):327-33. doi: 10.1053/meta.2002.29963. Metabolism. 2002. PMID: 11887169

3

Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice.

Dimayuga P, Cercek B, Oguchi S, Fredrikson GN, Yano J, Shah PK, Jovinge S, Nilsson J. Dimayuga P, et al. Among authors: nilsson j. Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):644-9. doi: 10.1161/01.atv.0000012455.62765.bf. Arterioscler Thromb Vasc Biol. 2002. PMID: 11950704

4

Decreased inducibility of TNF expression in lipid-loaded macrophages.

Ares MP, Stollenwerk M, Olsson A, Kallin B, Jovinge S, Nilsson J. Ares MP, et al. Among authors: nilsson j. BMC Immunol. 2002 Oct 6;3:13. doi: 10.1186/1471-2172-3-13. BMC Immunol. 2002. PMID: 12366867 Free PMC article.

5

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells.

Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, Ares MP, Nilsson J, Pachinger O, Weidinger F. Dichtl W, et al. Among authors: nilsson j. Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):58-63. doi: 10.1161/01.atv.0000043456.48735.20. Arterioscler Thromb Vasc Biol. 2003. PMID: 12524225

6

Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques.

Gonçalves I, Moses J, Dias N, Pedro LM, Fernandes e Fernandes J, Nilsson J, Ares MP. Gonçalves I, et al. Among authors: nilsson j. Stroke. 2003 Mar;34(3):616-22. doi: 10.1161/01.STR.0000058157.69113.F6. Epub 2003 Feb 13. Stroke. 2003. PMID: 12624281

7

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.

Fredrikson GN, Hedblad B, Berglund G, Alm R, Ares M, Cercek B, Chyu KY, Shah PK, Nilsson J. Fredrikson GN, et al. Among authors: nilsson j. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):872-8. doi: 10.1161/01.ATV.0000067935.02679.B0. Epub 2003 Mar 20. Arterioscler Thromb Vasc Biol. 2003. PMID: 12649091

8

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.

Fredrikson GN, Söderberg I, Lindholm M, Dimayuga P, Chyu KY, Shah PK, Nilsson J. Fredrikson GN, et al. Among authors: nilsson j. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):879-84. doi: 10.1161/01.ATV.0000067937.93716.DB. Epub 2003 Mar 20. Arterioscler Thromb Vasc Biol. 2003. PMID: 12649092

9

Autoantibodies against modified low-density lipoproteins in coronary artery disease.

Tornvall P, Waeg G, Nilsson J, Hamsten A, Regnström J. Tornvall P, et al. Among authors: nilsson j. Atherosclerosis. 2003 Apr;167(2):347-53. doi: 10.1016/s0021-9150(03)00021-2. Atherosclerosis. 2003. PMID: 12818418

10

[A vaccine for protection against atherosclerosis. Oxidized LDL plays a major role in the immunologic defence].

Nilsson J, Fredrikson GN. Nilsson J, et al. Lakartidningen. 2004 May 6;101(19):1700-1, 1704-5. Lakartidningen. 2004. PMID: 15188583 Review. Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,344 results

Search Page

Filters